Azitra (AZTR) Total Current Liabilities (2022 - 2026)
Azitra (AZTR) posted Total Current Liabilities of $1.5 million for Q1 2026, up 45.12% on a QoQ basis from $1.1 million in Q4 2025, and up 21.04% year-over-year from $1.3 million in Q1 2025.
Azitra (AZTR) Total Current Liabilities (2022 - 2026) Analysis & Trends
Azitra's Total Current Liabilities history runs 5 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- Quarterly Total Current Liabilities rose 21.04% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (up 21.04% YoY) and the FY2025 annual result came in at $1.1 million, down 22.38% from the prior year.
- Total Current Liabilities was $1.5 million for Q1 2026 at Azitra, up from $1.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $2.2 million in Q4 2022 and bottomed at $1.1 million in Q4 2025.
- A 5-year average of $1.5 million and a median of $1.5 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Current Liabilities slipped 27.85% — and 2025, when it soared 32.03%.
- Azitra's Total Current Liabilities stood at $2.2 million in 2022, then decreased by 27.85% to $1.6 million in 2023, then decreased by 14.18% to $1.4 million in 2024, then dropped by 22.38% to $1.1 million in 2025, then surged by 45.12% to $1.5 million in 2026.
- Business Quant data shows AZTR's Total Current Liabilities at $1.5 million in Q1 2026, $1.1 million in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - | 65.44 Mn |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 13.42 Mn |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn | 1.81 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn | 3.88 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn | 5.11 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn | 1.58 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn | 1.35 Bn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - | 289.60 Mn |
| 10 | Azitra | 2.03 Mn | 2.03 Mn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.38 Mn |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.45 Mn |
| Jun 30, 2023 | 1.74 Mn |
| Dec 31, 2022 | 2.22 Mn |